ANAB Competitors & Alternatives
Compare AnaptysBio Inc with similar stocks in the same industry
Biotechnology
ANAB
Main Stock$59.43
Tradestie Score
58
Market Cap
$894.30M
Revenue Growth
-0.1%
Analyst Upside
+46.5%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CELC
Celcuity Inc. Common Stock
|
$90.21
|
$1.92B | - | 54 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$74.04
|
$1.90B | 444.1 | 55 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$38.20
|
$1.84B | - | 58 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$29.20
|
$1.81B | - | 64 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$5.63
|
$1.78B | - | 56 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$20.26
|
$1.78B | - | 62 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$17.28
|
$1.74B | - | 61 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$32.98
|
$1.68B | - | 56 | Compare |
|
MNKD
Mannkind Corporation
|
$3.93
|
$1.65B | - | 64 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$38.83
|
$1.63B | - | 67 | Compare |
More ANAB Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
224 stocks in this industry